ESC 365 - Genetically tailored therapy with flecainide for familial dilated cardiomyopathy

EHRA Premium Access

Genetically tailored therapy with flecainide for familial dilated cardiomyopathy

Session: Rare inherited cardiac conditions

Topic: Clinical

Speaker: Doctor J. Fernandez Sanchez (Granada, ES)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jose Antonio Fernandez Sanchez

Virgen de las Nieves University Hospital, Granada (Spain)

2 presentations

0 follower

3 more presentations in this session

First documented clinical case of arrhythmogenic heterozygous TECRL variant

Speaker: Doctor A. Porretta (Lausanne, CH)

A novel mutation in LIM domain-binding protein 3 (LDB3) responsible for cardiomyopathy in association with ventricular preexcitation and conduction abnormalities

Speaker: Doctor D. Siddharthan (New Delhi, IN)

A rare case of Andersen-Tawil Syndrome Type-1 with concealed clinical features

Speaker: Associate Professor B. Hunuk (Istanbul, TR)

Access the full session

Rare inherited cardiac conditions

Speakers: Doctor J. Fernandez Sanchez, Doctor A. Porretta, Doctor D. Siddharthan, Associate Professor B. Hunuk

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources